StemCell Therapy

REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Arthur Levin, PhD, to the Company’s Strategic Advisory Board (SAB). Dr. Levin is a founding member of Avidity Biosciences, a biopharmaceutical company committed to delivering a new class of RNA therapeutics called antibody oligonucleotide conjugates, and currently serves on its Board of Directors. He brings three decades of experience developing oligonucleotides to Codexis as it continues to onboard customers for its Enzyme Catalyzed Oligonucleotide (ECO) Synthesis™ manufacturing platform.

Link:
Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board

TORONTO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that it has signed an advisory agreement with Mr. Matthew Azrieli. Mr. Azrieli is a current shareholder of PharmAla Biotech.

Read the original here:
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), February 6, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today outlines the design of new clinical trials within its Acute on-Chronic Liver Failure (ACLF) pipeline, with several clinical data readouts by end of 2025.

Originally posted here:
GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025

Topline data from Phase 3 ONWARD trials for Alumis’ ESK-001 in moderate-to-severe plaque psoriasis on track for readout in first half of 2026; Topline data from Phase 2b LUMUS trial in systemic lupus erythematosus on track for readout in 2026

Original post:
Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative...

SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter and full year 2024 financial results on Thursday, February 27, 2025 after the market closes. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business update.

The rest is here:
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Execution of a share buyback agreement for up to €2 billion

Follow this link:
Press Release: Execution of a share buyback agreement for up to €2 billion

Phase 3 FRONTIER3 interim analysis data presented at EAHAD 2025 showed that 74.3% of children on once-weekly Mim8 prophylaxis experienced zero treated bleeds

View original post here:
Novo Nordisk A/S: Once-weekly Mim8 is well-tolerated and efficacious in children living with haemophilia A with and without inhibitors

This 'itchy' symptom is an early sign of diabetes that people often miss; know more about it  The Times of India

See original here:
This 'itchy' symptom is an early sign of diabetes that people often miss; know more about it - The Times of India

Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024  ABC News

Read this article:
Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024 - ABC News

Abbotts Above the Bias Film Reveals Misconceptions Can Impact Diabetes Care  MultiVu

Go here to see the original:
Abbotts Above the Bias Film Reveals Misconceptions Can Impact Diabetes Care - MultiVu

Incidence of type 2 diabetes and metabolic syndrome by Occupation 10-Year follow-up of the Gutenberg Health Study  BMC Public Health

Continued here:
Incidence of type 2 diabetes and metabolic syndrome by Occupation 10-Year follow-up of the Gutenberg Health Study - BMC Public Health

The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes  Nature.com

View original post here:
The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes - Nature.com

Q&A: Diabetes care for the aging population in the digital age  Medical Xpress

View post:
Q&A: Diabetes care for the aging population in the digital age - Medical Xpress

Nanoparticle Therapy has Potential to Reprogram the Immune System in Type 1 Diabetes  Managed Healthcare Executive

Read the rest here:
Nanoparticle Therapy has Potential to Reprogram the Immune System in Type 1 Diabetes - Managed Healthcare Executive

Assessing type-2 diabetes risk based on the Indian diabetes risk score among adults aged 45 and above in India  Nature.com

Read the rest here:
Assessing type-2 diabetes risk based on the Indian diabetes risk score among adults aged 45 and above in India - Nature.com

Muscle quality index is correlated with insulin resistance and type 2 diabetes mellitus: a cross-sectional population-based study  BMC Public Health

See the rest here:
Muscle quality index is correlated with insulin resistance and type 2 diabetes mellitus: a cross-sectional population-based study - BMC Public Health

Single-cell atlas of human pancreatic islet and acinar endothelial cells in health and diabetes  Nature.com

Read more:
Single-cell atlas of human pancreatic islet and acinar endothelial cells in health and diabetes - Nature.com

Sugary Drinks Fuel Millions of Diabetes and CVD Cases  Medscape

Read the rest here:
Sugary Drinks Fuel Millions of Diabetes and CVD Cases - Medscape

1 in 5 UK adults estimated to have diabetes in new record high  Euronews

See the original post:
1 in 5 UK adults estimated to have diabetes in new record high - Euronews

New, increasingly widely used diabetes medication may have additional health benefits for older adults  Medical Xpress

Read the original post:
New, increasingly widely used diabetes medication may have additional health benefits for older adults - Medical Xpress